Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Blood|December 4, 2013
Suboptimal dosing of rituximab in male and female patients with DLBCLMichael Pfreundschuh, Carsten Müller, Samira Zeynalova, et al.
Bone Marrow Transplantation|July 25, 2020
Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapyTorben Rixecker, Vadim Lesan, Manfred Ahlgrimm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphomaGerhard Held, Niels Murawski, Marita Ziepert, et al.
Blood|June 19, 2014
The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomasNiels Murawski, Gerhard Held, Marita Ziepert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Impact of rituximab and radiotherapy on outcome of patients with aggressive B-cell lymphoma and skeletal involvementGerhard Held, Samira Zeynalova, Niels Murawski, et al.
Blood|February 17, 2012
The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCLCarsten Müller, Niels Murawski, Martin H J Wiesen, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2020
Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potentialMoritz Bewarder, Gerhard Held, Lorenz Thurner, et al.
Journal of Autoimmunity|May 26, 2015
The molecular basis for development of proinflammatory autoantibodies to progranulinLorenz Thurner, Natalie Fadle, Evi Regitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Optimization of rituximab for the treatment of diffuse large B-cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the german high-grade non-Hodgkin lymphoma study groupMichael Pfreundschuh, Viola Poeschel, Samira Zeynalova, et al.
British Journal of Haematology|October 10, 2017
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patientsMichael Pfreundschuh, Niels Murawski, Samira Zeynalova, et al.
Pageof 3